Literature DB >> 23970032

Oncogenic function of p34SEI-1 via NEDD4‑1‑mediated PTEN ubiquitination/degradation and activation of the PI3K/AKT pathway.

Samil Jung1, Chengping Li, Dongjun Jeong, Soonduck Lee, Jiyeon Ohk, Meeyoung Park, Songyi Han, Jingjing Duan, Changjin Kim, Young Yang, Keun-Il Kim, Jong-Seok Lim, Young-Sook Kang, Myeong-Sok Lee.   

Abstract

A 34-KD protein encoded by the SEI-1 gene (p34(SEI‑1)), is a relatively recently discovered oncoprotein that has multiple important biological functions. Our data show that p34(SEI-1) enhances cancer cell survival and promotes tumorigenesis by downregulating the tumor suppressor PTEN, a negative regulator of the PI3K/AKT signaling pathway, and therefore activating the PI3K/AKT signaling pathway. In this process, p34(SEI-1) positively affects NEDD4-1 gene expression both at the transcriptional and protein levels. Furthermore, the expression levels of p34(SEI-1) and NEDD4-1 were found to be coordinated in tumor tissues obtained from patients with breast cancer. We also show that p34(SEI-1) affects the subcellular localization of PTEN.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23970032     DOI: 10.3892/ijo.2013.2064

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  23 in total

1.  NEDD4 is involved in acquisition of epithelial-mesenchymal transition in cisplatin-resistant nasopharyngeal carcinoma cells.

Authors:  Shaoyan Feng; Guangwei Yang; Haidi Yang; Zibin Liang; Rongkai Zhang; Yunping Fan; Gehua Zhang
Journal:  Cell Cycle       Date:  2017-04-05       Impact factor: 4.534

Review 2.  Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases.

Authors:  Vladimir N Uversky; Vrushank Davé; Lilia M Iakoucheva; Prerna Malaney; Steven J Metallo; Ravi Ramesh Pathak; Andreas C Joerger
Journal:  Chem Rev       Date:  2014-05-15       Impact factor: 60.622

3.  Type I γ Phosphatidylinositol Phosphate 5-Kinase i5 Controls the Ubiquitination and Degradation of the Tumor Suppressor Mitogen-inducible Gene 6.

Authors:  Ming Sun; Jinyang Cai; Richard A Anderson; Yue Sun
Journal:  J Biol Chem       Date:  2016-08-24       Impact factor: 5.157

4.  Inhibition of NEDD4 inhibits cell growth and invasion and induces cell apoptosis in bladder cancer cells.

Authors:  Wu Wen; Jingying Li; Longwang Wang; Yifei Xing; Xuechao Li; Hailong Ruan; Xiaoqing Xi; Jianhua Xiong; Renrui Kuang
Journal:  Cell Cycle       Date:  2017-07-26       Impact factor: 4.534

Review 5.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04

6.  Anticancer effect of deoxypodophyllotoxin induces apoptosis of human prostate cancer cells.

Authors:  Sheng Hu; Qiang Zhou; Wan-Rui Wu; Yi-Xing Duan; Zhi-Yong Gao; Yuan-Wei Li; Qiang Lu
Journal:  Oncol Lett       Date:  2016-08-03       Impact factor: 2.967

Review 7.  NEDD4: a promising target for cancer therapy.

Authors:  Xiantao Ye; Lixia Wang; Bingxue Shang; Zhiwei Wang; Wenyi Wei
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

8.  Nutrient/serum starvation derived TRIP-Br3 down-regulation accelerates apoptosis by destabilizing XIAP.

Authors:  Chengping Li; Samil Jung; Soonduck Lee; Dongjun Jeong; Young Yang; Keun-Il Kim; Jong-Seok Lim; Chung-Il Cheon; Changjin Kim; Young-Sook Kang; Myeong-Sok Lee
Journal:  Oncotarget       Date:  2015-04-10

9.  Nedd4-1 is an exceptional prognostic biomarker for gastric cardia adenocarcinoma and functionally associated with metastasis.

Authors:  Aiqin Sun; Guanzhen Yu; Xiaoyan Dou; Xiaowei Yan; Wannian Yang; Qiong Lin
Journal:  Mol Cancer       Date:  2014-11-14       Impact factor: 27.401

10.  Lung neuroendocrine tumors: correlation of ubiquitinylation and sumoylation with nucleo-cytosolic partitioning of PTEN.

Authors:  Stéphane Collaud; Verena Tischler; Andrej Atanassoff; Thomas Wiedl; Paul Komminoth; Christian Oehlschlegel; Walter Weder; Alex Soltermann
Journal:  BMC Cancer       Date:  2015-02-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.